Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?

Abstract

Aims/hypothesis We examined incidence, prevalence and mortality from type 2 diabetes mellitus in a Scottish population over 12 years, and evaluated the effects on prevalence of increasing incidence and decreasing mortality. Materials and methods We used a diabetes clinical information system in Tayside (population 387,908), Scotland, to identify new cases of type 2 diabetes between 1993 and 2004 and to calculate incidence rates and mid-year prevalence. We defined mortality rates as the number of deaths of diabetic people divided by mid-year prevalence. We used logistic and Poisson regression to analyse trends. We then modelled the increase in prevalence for each year for three scenarios, based on whether mortality or incidence rates remained unchanged from 1993. Results There was a doubling in incidence and prevalence of type 2 diabetes in Tayside over the 12 years, with statistically significant increasing trends of 6.3 and 6.7% per year respectively. The mortality rate decreased. If incidence and mortality had remained at 1993 levels, there would have been an increase in prevalence of 855 per 100,000 in 2003, accounting for 60.1% of the actual increase of 1,423 per 100,000. If there had been no mortality decrease, prevalence in 2003 would have been very similar to the actual prevalence observed. Conclusions/interpretation Decreasing mortality rates in Tayside had less effect on the increase in prevalence than did increasing incidence. Even if incidence and mortality remain unchanged, prevalence will increase by over 20% in the next decade.

The Danish National Diabetes Register: trends in incidence, prevalence and mortality

“…This has shown [14] a similar prevalence of diabetes in 1996 (1.94% compared with 1.89% in Denmark) and similar increase in prevalence (6.7% per year compared with 6.3% per year [men] and 6.6% per year [women] in Denmark). In the Skaraborg region (population about 300,000) of Sweden, a registry based on clinical recordings from patients [15] showed a prevalence of 3.2% in 1995, somewhat higher than found in Denmark.…”

Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013

“…Explanations for the differing prevalence and incidence estimates of type 2 diabetes could also be influenced by demographic changes (such as an ageing population and immigration), effects of changes in treatment patterns (such as earlier GLD initiation [6]) and increased survival rates in the diabetes population. Studies from Canada, Finland, the UK and the USA have reported declining all-cause mortality in the diabetic population but increasing incidence of diabetes [4,[21][22][23], suggesting that there has been successful treatment of diabetes and diabetes-related complications but insufficient lifestyle-changing programmes to prevent diabetes.…”

Tendência da mortalidade por diabetes melito em capitais brasileiras, 1980-2007

“…Esse padrão de distribuição das taxas de mortalidade não acompanha, de modo geral, aquele evidenciado em estudos epidemiológicos realizados em diferentes países que constataram a redução da mortalidade por diabetes melito nas últimas décadas, embora com aumento da sua incidência e prevalência (4,6,14,15). Entre as possíveis explicações para esse declínio, são apontadas tendências de redução da mortalidade por doença coronariana e por acidente vascular cerebral, menor exposição a fatores de risco como o tabagismo, busca ativa de casos e rastreamento levando ao diagnóstico mais precoce da doença e intervenções médicas para redução dos níveis de glicemia, colesterolemia e pressão arterial (5,26).…”

“…A prevalência de diabetes melito no Brasil correspondeu a 7,6% em um estudo realizado com amostra representativa da população urbana entre 30 e 69 anos de idade (13), apresentando magnitude comparável à de países da Europa e da América do Norte (4,6,14). Indivíduos com diabetes apresentam maior risco de vida, principalmente, por alterações cardiovasculares circulatórias e renais (15,16).…”